Loading...
XSHG
603896
Market cap561mUSD
Apr 03, Last price  
20.64CNY
1D
1.18%
1Q
2.64%
Name

Zhejiang Shouxiangu Pharmaceuticl Co Ltd

Chart & Performance

D1W1MN
P/E
16.08
P/S
5.22
EPS
1.28
Div Yield, %
1.89%
Shrs. gr., 5y
1.23%
Rev. gr., 5y
8.93%
Revenues
784m
-5.39%
177,752,928253,030,064301,591,563301,912,435314,879,954369,963,314511,451,922546,758,533636,050,563767,137,327829,071,599784,347,256
Net income
254m
-8.39%
34,022,82154,048,12869,251,16462,643,86180,977,81688,879,887107,652,897123,895,326151,712,138200,826,526277,783,036254,480,058
CFO
315m
-7.68%
45,356,80765,849,813102,899,07585,029,30095,516,877110,803,595171,513,111207,918,192256,358,637296,699,128341,283,418315,057,385
Dividend
Jun 20, 20240.39 CNY/sh
Earnings
May 16, 2025

Profile

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale, crocus sativus, and other health products. The company was founded in 1997 and is based in Jinhua, China.
URL
sxg1909.com
IPO date
Employees
Domiciled in
BE
Incorporated in
BE

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
784,347
-5.39%
829,072
8.07%
Cost of revenue
545,937
533,597
Unusual Expense (Income)
NOPBT
238,410
295,475
NOPBT Margin
30.40%
35.64%
Operating Taxes
431
453
Tax Rate
0.18%
0.15%
NOPAT
237,979
295,022
Net income
254,480
-8.39%
277,783
38.32%
Dividends
(92,780)
(60,317)
Dividend yield
1.47%
0.79%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
372,161
277,846
Long-term debt
388,129
444,532
Deferred revenue
49,984
41,298
Other long-term liabilities
1
Net debt
(809,387)
(866,137)
Cash flow
Cash from operating activities
315,057
341,283
CAPEX
(414,540)
Cash from investing activities
(1,298,783)
Cash from financing activities
290,081
335,839
FCF
165,960
153,847
Balance
Cash
1,503,962
1,554,712
Long term investments
65,714
33,802
Excess cash
1,530,459
1,547,061
Stockholders' equity
1,370,363
1,049,276
Invested Capital
1,587,228
1,595,735
ROIC
14.95%
22.78%
ROCE
8.05%
11.16%
EV
Common stock shares outstanding
195,754
192,543
Price
32.24
-18.71%
39.66
-11.12%
Market cap
6,311,105
-17.35%
7,636,249
-11.60%
EV
5,602,650
6,770,113
EBITDA
314,633
359,852
EV/EBITDA
17.81
18.81
Interest
25,048
13,028
Interest/NOPBT
10.51%
4.41%